Company
Intercure Ltd. (INCR)
Standardized SEC financial data for Intercure Ltd. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001857030 · NASDAQ · Pharmaceutical Preparations.
Gross margin
12.7%
Net margin
-30.5%
Revenue growth (YoY)
-32.8%
Return on equity
-18.3%
Ratios for fiscal year 2024, standardized from SEC filings.
Income statement
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Revenue | $8.9M | $65.0M | $219.7M | $388.7M | $355.6M | $238.8M |
| Cost of revenue |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Goodwill | — | $190.1M | $268.3M | $284.2M | $221.1M | $224.6M |
| Total assets |
Get INCR data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/INCR/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/INCR/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"